Monash University, Alfred Hospital, Central Clinical School, Women's Health Program, Commercial Road, Prahran, Victoria 3181, Australia.
Expert Opin Pharmacother. 2010 Jun;11(8):1329-41. doi: 10.1517/14656561003742962.
Over the last decade, the management of the menopause has attracted extensive public and professional debate and has become one of the most controversial areas in clinical practice.
This review provides an overview of the field, primarily from a clinical practice perspective. However, as we have incorporated in this 'big-picture' snapshot of the field both conventional and complementary approaches to managing the menopause, it is not an exhaustive review of the literature.
By reviewing menopausal management from the perspective of practicing clinicians, we hope readers will gain insight into decision making processes appropriate for dealing with symptomatic women.
Although most women do not require pharmacotherapy for menopausal symptoms, many are severely affected by estrogen deficiency at and beyond menopause and, for such women, hormone therapy is important if they are to retain an acceptable quality of life. This article considers the drug treatment of the symptomatic postmenopausal woman and the safety issues related to these medications.
在过去的十年中，更年期管理引起了广泛的公众和专业辩论，并成为临床实践中最具争议的领域之一。
本篇综述主要从临床实践的角度提供了该领域的概述。然而，由于我们在这个领域的“全景图”快照中纳入了传统和补充方法来管理更年期，因此这并不是对文献的详尽回顾。
通过从执业临床医生的角度来审查更年期管理，我们希望读者能够深入了解针对有症状女性的决策过程。
尽管大多数女性不需要药物治疗更年期症状，但许多女性在更年期及以后都会受到雌激素缺乏的严重影响，对于这些女性来说，如果要保持可接受的生活质量，激素治疗很重要。本文考虑了有症状绝经后妇女的药物治疗以及与这些药物相关的安全问题。
